Bullish run on silver to lift prices '400% in three years':

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Bullish run on silver to lift prices '400% in three years': Williams

Marc Howe | November 14, 2012
ian_williams_silver_five_fold_increase

Fund manager Ian Williams claims a long-term bullish trend for silver will raise prices for the precious metal five-fold within the next three years.

The Daily Telegraph reports that Williams, manager of the WAY Charteris Gold Fund, believes that silver will outperform gold significantly and that macro fundamentals such as President Obama's election to a second term will continue to support major gains in precious metals.

Williams anticipates a long-term bullish trend for silver and possesses sufficient confidence in his predictions to provide an exact month for when the precious metal completes a projected five-fold price increase.

Silver is about to enter a sustained bull market that will take the price from the current level of $32 an ounce to $165 an ounce and we expect this price to be hit at the end of October 2015.

This forecast is based entirely using technical & cyclical analysis and is in keeping with the mathematical form displayed so far in the bull run that has taken Silver from $8 an ounce in 2008 to its current price of $32 an ounce – having hit $50 an ounce in 2011.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the Expansion of Data Diode Solutions Market Growth

Updated Category News Views 238

Understanding the Data Diode Solutions Market The Data Diode Solutions Market is rapidly evolving, with significant growth observed over recent years. This market is projected to increase from its current valuation of millions to an anticipated valuation surpassing USD 1.29 billion by the year 2033. This upward trajectory is driven by a compound annual growth rate (CAGR)...

Continue Reading
D.R. Horton Surpasses Expectations Amidst Housing Supply Crunch

Updated Category News Views 294

D.R. Horton Surpasses Revenue and Profit Expectations D.R. Horton has recently reported remarkable first-quarter results that exceeded analysts' expectations for both revenue and profit. This achievement comes in the context of a continuous shortage of existing homes in the U.S. housing market, which has significantly boosted the demand for new home sales, even amidst...

Continue Reading
Sustainable Innovations on the MS Mitsui Ocean Fuji Cruise Ship

Updated Category News Views 290

Introduction to the MS Mitsui Ocean Fuji The cruise industry is evolving, and the MS Mitsui Ocean Fuji, a remarkable vessel, is at the forefront of this change. This Japanese cruise ship, operated by Mitsui O.S.K. Lines, is an impressive example of how modern technology can meet sustainable practices in marine operations. History and Transition of the Ship Originally...

Continue Reading
South Korea's Trade Deal with U.S.: Seeking Rational Terms

Updated Category News Views 265

South Korea's Trade Deal Approaches Negotiation Hurdles In the world of international trade, negotiations can swing between promise and peril. Recently, the South Korean President Lee Jae Myung has raised significant concerns regarding a proposed trade deal with the United States, valued at $350 billion. This deal, originally discussed with former President Donald Trump,...

Continue Reading
Cullinan Therapeutics' CLN-049 Gains FDA Fast Track Approval

Updated Category News Views 141

Cullinan Therapeutics' New Milestone in Cancer Treatment Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, has recently received a significant boost in its fight against acute myeloid leukemia (AML). The U.S. Food and Drug Administration (FDA) has awarded Fast Track designation to its investigational drug CLN-049. This crucial milestone allows for...

Continue Reading